AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23812851 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-open rotator cuff repair (Group I)
Number of subjects: 125
Study 23812851 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repair (Group II)
Number of subjects: 125
Study 23812851 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Group I and Group II
Number of subjects: 125
Study 22790892 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic carpal tunnel release (ECTR)
Number of subjects: 79
Study 22790892 — intervention group
Group type: COMPARATOR
Intervention: Open carpal tunnel release (OCTR)
Number of subjects: 79
Study 21254673 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block (Group A)
Number of subjects: 80
Study 21254673 — intervention group
Group type: COMPARATOR
Intervention: Pump of vein odynolysis (Group B)
Number of subjects: 80
Study 18957490 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day participatory-style educational program
Number of subjects: 304
Study 18957490 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 304
Study 15662290 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ) 20 mg t.i.d.
Number of subjects: 166
Study 15662290 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pbo) t.i.d.
Number of subjects: 166
Study 12891544 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric electrical stimulation ON
Number of subjects: 33
Study 10233186 — intervention group
Group type: EXPERIMENTAL
Intervention: bosentan 700 mg
Number of subjects: 18
Study 10233186 — intervention group
Group type: EXPERIMENTAL
Intervention: misoprostol 400 mg
Number of subjects: 18
Study 10233186 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study 8904256 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vecuronium (0.3 mg kg‐1)
Number of subjects: 0
Study 8904256 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium (0.1 mg kg‐1)
Number of subjects: 0
Study 1687320 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 20
Study 1687320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 29555790 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorothiazide 500 mg
Number of subjects: 3244
Study 29555790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3244
Study 29469431 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical nursing path integrated with holistic nursing
Number of subjects: 226
Study 29469431 — intervention group
Group type: COMPARATOR
Intervention: Holistic nursing (control group)
Number of subjects: 226
Study 23662595 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based Triple P 'Positive Parenting Programme'
Number of subjects: 0
Study 22046993 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional group counseling (24-week intervention)
Number of subjects: 43
Study 22046993 — intervention group
Group type: COMPARATOR
Intervention: Comparison Group I (51 low-achieving students)
Number of subjects: 43
Study 22046993 — intervention group
Group type: COMPARATOR
Intervention: Comparison Group II (43 moderate or high academic achieving students)
Number of subjects: 43
Study 19663893 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid withdrawal
Number of subjects: 132
Study 19663893 — intervention group
Group type: COMPARATOR
Intervention: Continued low-dose steroids
Number of subjects: 132
Study 19663893 — intervention group
Group type: COMPARATOR
Intervention: Steroid withdrawal and continued low-dose steroids
Number of subjects: 132
Study 18445841 — intervention group
Group type: EXPERIMENTAL
Intervention: [(177)Lu-DOTA(0),Tyr(3)]octreotate
Number of subjects: 504
Study 17008577 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged care intervention participants received computerized motivational feedback at baseline and at 3, 6, and 12 months, and were offered a 6-session psychological counseling and pharmacological cessation treatment program.
Number of subjects: 322
Study 17008577 — intervention group
Group type: COMPARATOR
Intervention: Brief contact control participants received a self-help guide and referral list of local smoking-treatment providers.
Number of subjects: 322
Study 17008577 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged care intervention
Number of subjects: 322
Study 14574348 — intervention group
Group type: EXPERIMENTAL
Intervention: almond‐LCD (84 g/day of almonds, 39% total fat, 25% MUFA, 32% carbohydrate)
Number of subjects: 65
Study 14574348 — intervention group
Group type: EXPERIMENTAL
Intervention: almond‐LCD (84 g/day of almonds)
Number of subjects: 65
Study 14574348 — intervention group
Group type: COMPARATOR
Intervention: CHO‐LCD (self‐selected complex carbohydrates, 18% total fat, 5% MUFA, 53% carbohydrate)
Number of subjects: 65
Study 14574348 — intervention group
Group type: COMPARATOR
Intervention: CHO‐LCD (self‐selected complex carbohydrates)
Number of subjects: 65
Study 10751249 — intervention group
Group type: EXPERIMENTAL
Intervention: AG284
Number of subjects: 33
Study 10751249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 8703461 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenburg posture (head-down, 15 degrees from horizontal)
Number of subjects: 15
Study 8703461 — intervention group
Group type: COMPARATOR
Intervention: Supine posture
Number of subjects: 15
Study 8703461 — intervention group
Group type: COMPARATOR
Intervention: Head-up posture (10 degrees from horizontal)
Number of subjects: 15
Study 1301232 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg propranolol
Number of subjects: 15
Study 1301232 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac volume load
Number of subjects: 15
Study 3859636 — intervention group
Group type: EXPERIMENTAL
Intervention: Active dentifrice containing 0.8% sodium monofluorophosphate and 1.3% formalin
Number of subjects: 67
Study 3859636 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice (lacking active ingredients)
Number of subjects: 67
Study 31382210 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (pulse of 200 μs, frequency at 10 Hz, in motor threshold) for 20 min followed by 30 min of vocal therapy
Number of subjects: 27
Study 31382210 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS for 20 min followed by 30 min of vocal therapy
Number of subjects: 27
Study 29073768 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention video (n = 225)
Number of subjects: 427
Study 29073768 — intervention group
Group type: COMPARATOR
Intervention: Control group (sudden infant death syndrome video, n = 202)
Number of subjects: 427
Study 26730890 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive urodynamic testing
Number of subjects: 29
Study 26730890 — intervention group
Group type: COMPARATOR
Intervention: Basic clinical assessment with non-invasive tests
Number of subjects: 29
Study 22685122 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydration condition (Hyd)
Number of subjects: 0
Study 22685122 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydration condition (Dehyd)
Number of subjects: 0
Study 22685122 — intervention group
Group type: COMPARATOR
Intervention: Control group (Cont)
Number of subjects: 0
Study 20202675 — intervention group
Group type: EXPERIMENTAL
Intervention: Silorane System Adhesive (2-step self-etch adhesive)
Number of subjects: 0
Study 18818443 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of donepezil (Aricept) daily for 6 weeks, increased to 10 mg daily for another 6 weeks, followed by cognitive training for 2 weeks and maintained for 1 year
Number of subjects: 168
Study 18818443 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily for 6 weeks, followed by cognitive training for 2 weeks and maintained for 1 year
Number of subjects: 168
Study 16135900 — intervention group
Group type: EXPERIMENTAL
Intervention: CPG 7909 + Engerix-B
Number of subjects: 0
Study 16135900 — intervention group
Group type: COMPARATOR
Intervention: Saline + Engerix-B (Control)
Number of subjects: 0
Study 16135900 — intervention group
Group type: EXPERIMENTAL
Intervention: CPG 7909 alone
Number of subjects: 0
Study 11994052 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1500 mg day-1)
Number of subjects: 26
Study 11994052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 11994052 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene (50-100 mg for 5 days) with Metformin
Number of subjects: 26
Study 11994052 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene (50-100 mg for 5 days) with Placebo
Number of subjects: 26
Study 10102252 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss after 3 weeks
Number of subjects: 54
Study 10102252 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss between week 3 and week 20
Number of subjects: 54
Study 10102252 — intervention group
Group type: COMPARATOR
Intervention: Restarting sulfonylureas after week 3
Number of subjects: 54
Study 7772427 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid 15 mg kg‐1
Number of subjects: 29
Study 2268019 — intervention group
Group type: EXPERIMENTAL
Intervention: Unlimited clear fluid ingestion up to two hours before surgery
Number of subjects: 228
Study 2268019 — intervention group
Group type: COMPARATOR
Intervention: Unlimited clear fluid ingestion up to two and a half hours before surgery
Number of subjects: 228
Study 442002 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraderma injection of a suspension of irradiated autologous tumour-cells mixed with intradermal BCG
Number of subjects: 52
Study 442002 — intervention group
Group type: COMPARATOR
Intervention: Non-autograft group
Number of subjects: 52
Study 442002 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study 31272931 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 10000
Study 31272931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10000
Study 28097266 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine posture during first filling cystometry
Number of subjects: 71
Study 28097266 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine posture
Number of subjects: 71
Study 28097266 — intervention group
Group type: EXPERIMENTAL
Intervention: Second filling cystometry
Number of subjects: 71
Study 28097266 — intervention group
Group type: COMPARATOR
Intervention: Erect posture
Number of subjects: 71
Study 25340318 — intervention group
Group type: EXPERIMENTAL
Intervention: 36IPT
Number of subjects: 1006
Study 25340318 — intervention group
Group type: EXPERIMENTAL
Intervention: 36IPT with ART
Number of subjects: 1006
Study 23688859 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclaimer
Number of subjects: 342
Study 23688859 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning
Number of subjects: 342
Study 23688859 — intervention group
Group type: COMPARATOR
Intervention: Model control
Number of subjects: 342
Study 23688859 — intervention group
Group type: COMPARATOR
Intervention: Car control
Number of subjects: 342
Study 21860157 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 5% permethrin (group A)
Number of subjects: 120
Study 21860157 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ivermectin (200 μg/kg/dose) in a single dose (group B)
Number of subjects: 120
Study 21860157 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ivermectin (200 μg/kg/dose) in a double dose regimen (group C)
Number of subjects: 120
Study 19462326 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavor-enhanced tomato soup (1,200 mg/l MSG + 3 g/l celery powder)
Number of subjects: 120
Study 19462326 — intervention group
Group type: COMPARATOR
Intervention: Non-enhanced soup
Number of subjects: 120
Study 19462326 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavor-enhanced tomato soup
Number of subjects: 120
Study 16946093 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 100 microg LPS
Number of subjects: 16
Study 16946093 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 16
Study 12939535 — intervention group
Group type: EXPERIMENTAL
Intervention: Volleyball players
Number of subjects: 23
Study 12939535 — intervention group
Group type: EXPERIMENTAL
Intervention: Basketball players
Number of subjects: 23
Study 12939535 — intervention group
Group type: COMPARATOR
Intervention: Comparison between volleyball and basketball players
Number of subjects: 23
Study 10924300 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial pacing at 500 ms
Number of subjects: 12
Study 10924300 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial pacing at 300 ms
Number of subjects: 12
Study 10924300 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sotalol (1.5 mg. kg(‐1))
Number of subjects: 12
Study 10924300 — intervention group
Group type: COMPARATOR
Intervention: Repeated defibrillation
Number of subjects: 12
Study 8644832 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity-based therapy regimen (30 min each day)
Number of subjects: 3
Study 1899984 — intervention group
Group type: COMPARATOR
Intervention: Mouth‐to-mouth
Number of subjects: 17
Study 1899984 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth‐to-mask
Number of subjects: 17
Study 1899984 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag-valve-(soft) mask
Number of subjects: 17
Study 1899984 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag-valve-(rigid) mask
Number of subjects: 17
Study 1899984 — intervention group
Group type: EXPERIMENTAL
Intervention: Tube-valve-mask
Number of subjects: 17
Study 6733063 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated compression stockings worn by 104 patients
Number of subjects: 196
Study 6733063 — intervention group
Group type: COMPARATOR
Intervention: Control group (92 patients not wearing stockings)
Number of subjects: 196
Study 31213572 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual inhalation training (study group)
Number of subjects: 100
Study 31213572 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure (control group)
Number of subjects: 100
Study 30443533 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Control Exercise (MCE)
Number of subjects: 30
Study 30443533 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Education (PE)
Number of subjects: 30
Study 30443533 — intervention group
Group type: EXPERIMENTAL
Intervention: MCE plus PE
Number of subjects: 30
Study 30443533 — intervention group
Group type: COMPARATOR
Intervention: Control (PE)
Number of subjects: 30
Study 27121444 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril or Imidapril for 6 weeks
Number of subjects: 497
Study 24201696 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo daily for 20 weeks
Number of subjects: 170
Study 22776627 — intervention group
Group type: EXPERIMENTAL
Intervention: Helmet therapy
Number of subjects: 0
Study 22776627 — intervention group
Group type: COMPARATOR
Intervention: No helmet therapy
Number of subjects: 0
Study 20235838 — intervention group
Group type: EXPERIMENTAL
Intervention: ART with 4 weeks of cyclosporine
Number of subjects: 54
Study 20235838 — intervention group
Group type: COMPARATOR
Intervention: ART alone
Number of subjects: 54
Study 17701926 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind access (group 1)
Number of subjects: 100
Study 17701926 — intervention group
Group type: COMPARATOR
Intervention: Standard access using fluoroscopy (group 2)
Number of subjects: 100
Study 15791438 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual ROI definition (SUV[MAN])
Number of subjects: 0
Study 15791438 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed dimensions ROI definition (SUV15 mm)
Number of subjects: 0
Study 15791438 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed dimensions ROI definition (SUV50)
Number of subjects: 0
Study 15791438 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed dimensions ROI definition (SUV75)
Number of subjects: 0
Study 15791438 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum pixel value ROI definition (SUVmax)
Number of subjects: 0
Study 15791438 — intervention group
Group type: COMPARATOR
Intervention: Ordered Subsets Expectation Maximisation (OSEM)
Number of subjects: 0
Study 15791438 — intervention group
Group type: COMPARATOR
Intervention: Filtered Back-Projection (FBP)
Number of subjects: 0
Study 15791438 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual and 50% threshold ROIs for metabolic volumes
Number of subjects: 0
Study 15791438 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% threshold and maximum pixel ROIs
Number of subjects: 0
Study 15791438 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold-based and fixed dimension methods
Number of subjects: 0
Study 14717251 — intervention group
Group type: EXPERIMENTAL
Intervention: Social contextual approach
Number of subjects: 1118
Study 14717251 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of nurturant and involved parenting
Number of subjects: 1118
Study 14717251 — intervention group
Group type: EXPERIMENTAL
Intervention: Child antisocial behavior and deviant peer affiliations at Time 2
Number of subjects: 1118
Study 10422930 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided cannulation
Number of subjects: 95
Study 10422930 — intervention group
Group type: COMPARATOR
Intervention: Landmarks method
Number of subjects: 95
Study 7593436 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandostatin-LAR (20, 30, or 40 mg) administered via intramuscular injections at 28- or 42-day intervals
Number of subjects: 8
Study 7593436 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandostatin-LAR
Number of subjects: 8
Study 2294528 — intervention group
Group type: EXPERIMENTAL
Intervention: Helium-neon laser stimulation (Experimental Group, n = 41)
Number of subjects: 80
Study 2294528 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (Control Group, n = 39)
Number of subjects: 80
Study 568935 — intervention group
Group type: EXPERIMENTAL
Intervention: Amaranthus spp. leaves cooked without draining water
Number of subjects: 6
Study 568935 — intervention group
Group type: COMPARATOR
Intervention: Amaranthus spp. leaves cooked with water drained
Number of subjects: 6
Study 31986357 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 47
Study 31986357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 31986357 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib and Placebo
Number of subjects: 47
Study 31474649 — intervention group
Group type: EXPERIMENTAL
Intervention: Extragenic mutations bypassed the essentiality of 20 genes (22%); 15 of which have not been previously reported.
Number of subjects: 92
Study 31474649 — intervention group
Group type: EXPERIMENTAL
Intervention: Half of the bypass-suppressible genes were involved in mitochondria function; multiple genes regulating RNA processing were identified.
Number of subjects: 92
Study 31474649 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 suppressible genes were conserved in the budding yeast Saccharomyces cerevisiae; 13 of them were non-essential in that species.
Number of subjects: 92
Study 26150412 — intervention group
Group type: EXPERIMENTAL
Intervention: SCAMP (30% more parenteral nutrition amino acids)
Number of subjects: 150
Study 26150412 — intervention group
Group type: COMPARATOR
Intervention: Control parenteral nutrition regimen
Number of subjects: 150
Study 26150412 — intervention group
Group type: COMPARATOR
Intervention: SCAMP and Control
Number of subjects: 150
Study 26404684 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laparoscopic and thoracoscopic esophagectomy
Number of subjects: 154
Study 26404684 — intervention group
Group type: COMPARATOR
Intervention: 2D laparoscopic and thoracoscopic esophagectomy
Number of subjects: 154
Study 22410962 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate/high glycemic index (HC/HGI) diet
Number of subjects: 88
Study 22410962 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate/low glycemic index (HC/LGI) diet
Number of subjects: 88
Study 22410962 — intervention group
Group type: EXPERIMENTAL
Intervention: High MUFA/high glycemic index (HM/HGI) diet
Number of subjects: 88
Study 22410962 — intervention group
Group type: EXPERIMENTAL
Intervention: High MUFA/low glycemic index (HM/LGI) diet
Number of subjects: 88
Study 22410962 — intervention group
Group type: EXPERIMENTAL
Intervention: High saturated fat (HS) diet
Number of subjects: 88
Study 22410962 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat diets (HM/HGI and HM/LGI)
Number of subjects: 88
Study 21892112 — intervention group
Group type: EXPERIMENTAL
Intervention: Overnight wear of hydrogel and silicone hydrogel contact lenses in inexperienced and experienced wearers.
Number of subjects: 60
Study 21892112 — intervention group
Group type: COMPARATOR
Intervention: Overnight wear of contact lenses (CL).
Number of subjects: 60
Study 21892112 — intervention group
Group type: EXPERIMENTAL
Intervention: NITBUT and comfort scores after CL insertion.
Number of subjects: 60
Study 19651163 — intervention group
Group type: EXPERIMENTAL
Intervention: PYY3-36
Number of subjects: 8
Study 19651163 — intervention group
Group type: EXPERIMENTAL
Intervention: PYY1-36
Number of subjects: 8
Study 19651163 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 8
Study 17572382 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 53
Study 17572382 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral group therapy (CBGT)
Number of subjects: 53
Study 17572382 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (MBSR and CBGT)
Number of subjects: 53
Study 14996873 — intervention group
Group type: EXPERIMENTAL
Intervention: Hohmann procedure (distal osteotomy of the first metatarsal)
Number of subjects: 101
Study 14996873 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapidus procedure (arthrodesis of the first tarsometatarsal joint combined with soft-tissue procedure)
Number of subjects: 101
Study 14996873 — intervention group
Group type: COMPARATOR
Intervention: Both procedures (Hohmann and Lapidus)
Number of subjects: 101
Study 11899783 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine
Number of subjects: 0
Study 11899783 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine in combination with trastuzumab and newer molecular targeting agents
Number of subjects: 0
Study 11899783 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine in doublets or triplets with drugs other than anthracyclines and taxanes
Number of subjects: 0
Study 9272782 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine test
Number of subjects: 39